These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9092954)

  • 1. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
    Faught E
    Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.
    Reife RA; Pledger GW
    Epilepsia; 1997; 38 Suppl 1():S31-3. PubMed ID: 9092956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
    Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
    Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
    Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
    Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents.
    Ben-Menachem E
    Epilepsia; 1996; 37 Suppl 2():S4-S7. PubMed ID: 8641244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.
    Rosenfeld WE; Sachdeo RC; Faught RE; Privitera M
    Epilepsia; 1997; 38 Suppl 1():S34-6. PubMed ID: 9092957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.
    Ritter F; Glauser TA; Elterman RD; Wyllie E
    Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
    Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
    Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate monotherapy for partial onset seizures.
    Sachdeo RC; Reife RA; Lim P; Pledger G
    Epilepsia; 1997 Mar; 38(3):294-300. PubMed ID: 9070591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate efficacy in an infant with partial seizures refractory to conventional antiepileptic drugs.
    Veggiotti P; Longaretti F; Signorini S; Cardinali S; Lanzi G
    Seizure; 2004 Jun; 13(4):241-3. PubMed ID: 15121132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs.
    French JA
    Epilepsia; 1996; 37 Suppl 2():S23-S26. PubMed ID: 8641243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.